calendar
131 catalysts · 3,728 phase readout · 2,104 8k filing · 276 earnings · 172 phase 2 completion · 152 grant · 133 drug shortage
next 91 dayslessmore
MonWedFri
131 catalysts · 3,728 phase readout · 2,104 8k filing · 276 earnings · 172 phase 2 completion · 152 grant · 133 drug shortage
Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION
Sponsor: QUAGEN. Form: SYRUP. Route: ORAL
Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: GLENMARK SPECLT. Form: CREAM. Route: TOPICAL
Sponsor: MARKSANS PHARMA. Form: CAPSULE, DELAYED RELEASE. Route: ORAL
Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: IMPAX LABS. Form: CAPSULE. Route: ORAL
Sponsor: IMPAX LABS. Form: CAPSULE. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Therapy area: Oncology. Indication: Multiple Myeloma (Kahler Disease), Refractory Multiple Myeloma, Relapsed Multiple Myeloma
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL
Sponsor: ACCORD HLTHCARE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: CAPSULE. Route: ORAL
Therapy area: Metabolic Disorders. Indication: Type 2 Diabetes
Therapy area: Oncology. Indication: Chronic Myelomonocytic Leukemia (CMML)
Therapy area: Dermatology. Indication: Androgenic Alopecia
Therapy area: Central Nervous System, Mouth and Dental Disorders. Indication: Post-Operative Pain, Unspecified Mouth and Dental Disorders
Therapy area: Central Nervous System. Indication: Epilepsy
Therapy area: Central Nervous System. Indication: Post-Operative Pain
Therapy area: Metabolic Disorders. Indication: Type 2 Diabetes
Therapy area: Central Nervous System, Gastrointestinal, Genito Urinary System, Respiratory. Indication: Anorexia Nervosa, Unspecified Gastrointestinal Disorders, Unspecified Genito Urinary Disorders, Unspecified Respiratory Disorders
Therapy area: Infectious Disease. Indication: Rabies
Therapy area: Cardiovascular. Indication: Unspecified Cardiovascular Disorders
Therapy area: Infectious Disease. Indication: Neisseria meningitidis Infections
Therapy area: Genito Urinary System, Infectious Disease. Indication: End-Stage Kidney Disease (End-Stage Renal Disease or ESRD), Unspecified Bacterial Infections
Therapy area: Hematological Disorders. Indication: Anemia, Iron Deficiency Anemia
Therapy area: Oncology. Indication: Nasopharyngeal Cancer
Therapy area: Central Nervous System, Musculoskeletal Disorders. Indication: Osteoarthritis, Post-Operative Pain
Therapy area: Genito Urinary System, Oncology. Indication: Bladder Cancer, Bladder Carcinoma, Kidney Cancer (Renal Cell Cancer), Metastatic Transitional (Urothelial) Tract Cancer, Renal Stones/Calculi, Transitional Cell Cancer (Urothelial Cell Cancer), Transitional Cell Carcinoma (Urothelial Cell Carcinoma), Ureter Cancer, Urethral Cancer
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL